002044 美年健康
2025/06 - 中期2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-2.8463.6166.711-7.2570.769
总资产报酬率 ROA (%)-1.1261.4262.673-2.9970.330
投入资产回报率 ROIC (%)-1.3901.7833.339-3.6740.396

边际利润分析
销售毛利率 (%)33.03342.78342.78934.43639.456
营业利润率 (%)-5.6655.7248.112-4.7324.231
息税前利润/营业总收入 (%)-2.3328.47810.530-1.8817.755
净利润/营业总收入 (%)-5.4173.8226.140-5.8221.727

收益指标分析
经营活动净收益/利润总额(%)88.289130.093105.90854.528110.626
价值变动净收益/利润总额(%)1.0412.8455.835-3.42220.346
营业外收支净额/利润总额(%)6.148-3.388-4.2049.554-6.901

偿债能力分析
流动比率 (X)0.7450.7820.7900.7080.837
速动比率 (X)0.7240.7580.7620.6790.816
资产负债率 (%)56.06256.75956.77655.91753.627
带息债务/全部投入资本 (%)34.62634.39533.09033.03333.471
股东权益/带息债务 (%)140.116143.015149.301151.767152.658
股东权益/负债合计 (%)71.07069.25969.68471.71579.179
利息保障倍数 (X)-0.6302.8823.836-0.5612.042

营运能力分析
应收账款周转天数 (天)127.56795.02088.553107.26899.968
存货周转天数 (天)12.25212.88613.04111.9469.173